top of page


MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
Halifax, Nova Scotia, July 16, 2025  – MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has...

MedMira
12 minutes ago4 min read


MedMira Inc. and Lovell Announce Partnership to Increase Access to Reveal® G4 HIV-1/2 rapid test for VA, Department of Defence
Halifax, Nova Scotia, 17th of April, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) and Lovell® Government Services announced today that they...

MedMira
Apr 173 min read


MedMira Announces Partnership with MediGroup Physician Services in the United States
Halifax, Nova Scotia, 27th of February, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today its partnership with MediGroup, a...

MedMira
Feb 273 min read
MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada.
Halifax, Nova Scotia, 25th of February, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today its exclusive distribution agreement...

MedMira
Feb 253 min read


MedMira Receives Investigational Testing Authorizations for Multiplo® TP/HIV Self-Test and Non-Professional Use Applications
Halifax, Nova Scotia, 21st of January, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received Investigational...

MedMira
Jan 215 min read


MedMira receives Health Canada approval for its Reveal® G4 Rapid HIV-1/2 Test for Point-of-Care use
Halifax, Nova Scotia – January 14, 2025 – MedMira Inc. (MedMira) (TSXV: MIR) announced today that it has received today the approval from...

MedMira
Jan 143 min read
bottom of page